167. Mechanisms of Hormone Action Flashcards

1
Q

Desensitized and downregulated by phosphorylation or by endocytosis

A

GPCRs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Present as goiter and tachycardia

Elevated thyroid hormone and normal TSH level

Most common = inactivating mutation in thyroid hormone beta receptor

  • beta receptor becomes more active
  • other mutations exist
A

Resistance to thyroid hormone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

3 components:

1) Extracellular Ligand Binding domain
2) Single TM domain
3) Intracellular tyrosine kinase catalytic domain

Need to homo-dimerize to activate kinase domains that leads to phosphorylation of many downstream domains and proteins

A

Receptor tyrosine kinase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Autosomal recessive

Laron Dwarfism

Insensitivity to GH

Reported resistances to diabetes and cancer

A

Growth Hormone receptor mutations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

These receptors act like other tyrosine kinases, but signaling occurs via associate tyrosine kinase associated proteins (Janus Kinase - JAKs)

25 known ligands

Important ones:

  • Growth Hormone - needed for growth
  • Prolactin - needed for reproduction/lactation
  • Leptin - suppresses appetite
A

Cytokine Activated Receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

46XY, Genetically male
Phenotype - female

Androgen receptor mutated
Cells can’t sense testosterone
- thus, testosterone is converted to estrogen (reason why they look like females)

A

Complete androgen insensitivity syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Same structure as receptor tyrosine kinases except these receptors phosphorylate serine/threonine

Two types of receptors:

  • Type I - 12 genes
  • Type II - 5 genes

Type I and II interact to mediate signaling as dimers

A

Receptor Serine/Threonine Kinases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Autosomal recessive
- inactivating mutations

Early-onset morbid obesity

Hyperphagia

A

Leptin receptor mutations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Gain of function mutation of GPCRs

Autoantibodies made to TSH-Receptor
- increase sympathetic andrenergic activity and metabolic rate

A

Graves’ Disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

100 different types exist

Most sequence/structural variation is in the extracellular domain

Examples of ligands:

  • insulin
  • epidermal growth factor
  • platelet-derived growth factor
A

Receptor tyrosine kinases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Rickets type 2
- hereditary vitamin D resistance

Presents as:

  • Rickets
  • Alopecia in most pts
  • High levels of 1,25(OH)2VitaminD3
  • Variable degrees of hypocalcemia
  • Secondary hyperparathyroidism
A

Mutations in Vitamin D receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Made by cleavage of PIP2 by phospholipase C in the non-classical Gq protein GPCR pathway

Ligand for ligand-gated ER bound calcium channels

A

IP3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Stimulates and inhibit cAMP production by adenylate cyclase respectively

Classical pathway G proteins

A

Gs and Gi

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Nuclear receptor regulate ___ via:

1) ligand-dependent activation
2) ligand-dependent negative regulation

A

Gene transcription

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Example of a genetic defect that affects the tyrosine kinase receptor mechanism

Insulin receptor:

  • impaired insulin binding or signaling via mutations in insulin receptor
  • –> leads to severe insulin resistance

Most individuals die young (by age of 1yo)
- d/t inability to grow

A

Donohue syndrome (leprechaunism)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Induces phospholipase C mediated cleavage of PIP2 to IP3 and DAG

(non-classical G protein)

A

Gq

17
Q

Often discovered at puberty d/t no menses in a “woman”

Other findings:

  • absence of axillary and pubic hair in most cases
  • No ovaries
  • testes found intra-abdominally and/or in inguinal ring
  • No meaningful spermatogenesis as sperm cells need testosterone for initiation
  • Vagina often ends as blind pouch
A

Complete androgen insensitivity syndrome

18
Q

Loss of function of CaSR (calcium sensing receptor)

  • autosomal dominant mutation
  • GPCR mutation

Need to distinguish from primary hyperparathyroidism
- concentration of urine calcium will be high in patients with this disease

Low calcium in kidney, high calcium in blood

A

Familial Hypocalciuric Hypercalcemia

19
Q

Common features:

  • small (less than 1000 daltons)
  • lipophilic
  • Not directly encoded by the genome, rather synthesized from cholesterol by enzymes or sourced exogenously
A

Ligands for nuclear receptors

20
Q

7 TM helices

Coupled intracellularly to heterotrimeric protein - G protein, consisting of the alpha, beta, and gamma subunits

Extracellular domain determines ligand specificity

Intracellular domain determines function via G protein specificity

A

GPCR

21
Q

Example of a GPCR disease d/t loss of function of the GPCR mechanism or the vasopressin 2 receptor

Mutation in vasopressin 2 receptor that concentrates urine
- aquaporins can’t get to cell membrane in these patients

A

Nephrogenic Diabetes Insipidus

22
Q

5-HT2 serotonergic receptors

Alpha-1 adrenergic receptor

Vasopressin receptors

Angiotensin II receptor Type 1

A

Membrane receptors that use Gq proteins

23
Q
Thyroid hormone 
Estrogen 
Testosterone 
Progesterone 
Aldosterone 
Cortisol 
1,25 - (OH)2 - Vit D3
A

Classic Nuclear hormones

24
Q

Gain of function mutations of GPCRs
- hyperfunctional and sporadic

Somatic mutations > autonomous

Hyperfunctioning thyroid nodules (toxic adenomas) leading to hyperthyroidism

Low TSH, high thyroid hormone levels

A

TSH-receptor mutations

25
Q

Main action steps:

  1. Ligand binding
  2. For most receptors: Dimerization to either homo- or heterodimers
  3. Binding to Hormone Response Elements (HREs) = receptor specific DNA sequence close to the promotors of genes regulated by this particular receptor
  4. Optional: binding of co-activators
  5. Activation or repression of gene transcription
A

Nuclear receptor activity